Related Experiment Videos
Circulating perivascular dilatory neuropeptides in hypertension
L Edvinsson1, R Ekman, T Thulin
1Department of Internal Medicine, University Hospital, Lund, Sweden.
Summary
Circulating levels of calcitonin gene-related peptide (CGRP) and substance P were altered in severe hypertension. These neuropeptide levels normalized after blood pressure treatment, suggesting a role for vascular nerves in maintaining high blood pressure.
Area of Science:
- Neuroscience
- Cardiovascular Medicine
- Hypertension Research
Background:
- Perivascular neuropeptides' role in human hypertension is poorly understood.
- Vascular afferent nerves may influence blood pressure regulation.
Purpose of the Study:
- To investigate circulating levels of specific neuropeptides in severe hypertension.
- To determine if these levels change after hypertension treatment.
Main Methods:
- Measured calcitonin gene-related peptide (CGRP)-, substance P-, and vasoactive intestinal peptide-like immunoreactivity.
- Compared levels in 30 hypertensive patients to 31 normotensive controls.
- Assessed changes before and after blood pressure normalization.
Main Results:
- Hypertensive patients showed significantly different CGRP and substance P levels compared to controls.
- These differences disappeared after blood pressure treatment.
- Vasoactive intestinal peptide levels remained unchanged throughout.
Conclusions:
- Altered CGRP and substance P levels in hypertension suggest vascular nerve involvement.
- Normalization of these neuropeptides post-treatment supports their role in hypertension maintenance.
- Findings indicate vascular afferent nerves contribute to the pathophysiology of hypertension.